Quick Overview
Hypertensive disorders complicate 10-15% of pregnancies and remain a leading cause of maternal/fetal morbidity. NICE NG133 stratifies management by severity: gestational hypertension, pre-eclampsia, and severe pre-eclampsia, each with distinct diagnostic thresholds and treatment escalation. Timely recognition, appropriate antihypertensive therapy, and judicious use of magnesium sulfate for seizure prophylaxis are critical to prevent maternal stroke, eclampsia, and perinatal compromise.
Core Facts & Concepts
📊 Diagnostic Thresholds
- Gestational hypertension: BP ≥140/90 mmHg after 20 weeks without proteinuria/organ dysfunction
- Pre-eclampsia: BP ≥140/90 mmHg PLUS proteinuria (≥300 mg/24h or PCR ≥30 mg/mmol) OR organ dysfunction
- Severe pre-eclampsia: BP ≥160/110 mmHg OR severe organ/uteroplacental dysfunction

🚩 Organ Dysfunction Markers
- Acute kidney injury (creatinine ≥90 μmol/L)
- Liver involvement (transaminases >70 IU/L ± RUQ pain)
- Haematological: platelets <150×10⁹/L, DIC, haemolysis
- Neurological: eclampsia, stroke, persistent headache/visual disturbance
- Uteroplacental: fetal growth restriction, abnormal Doppler, stillbirth
💊 First-Line Antihypertensives (NICE NG133)
| Drug | Starting Dose | Maximum Dose | Notes |
|---|---|---|---|
| Labetalol | 100 mg BD PO | 800 mg TDS | Avoid in asthma |
| Nifedipine MR | 10 mg BD PO | 40 mg BD | Use modified-release |
| Methyldopa | 250 mg BD-TDS PO | 1 g TDS | Avoid postpartum (depression risk) |
Target BP: 135/85 mmHg (avoid over-treatment; maintain uteroplacental perfusion)
Problem-Solving Approach
Step-by-Step Management
- Confirm diagnosis: Repeat BP measurement after 30 min rest; quantify proteinuria (PCR or 24h urine)
- Assess severity: Bloods (FBC, U&E, LFT, urate), fetal monitoring (CTG, USS growth/Doppler)
- Initiate treatment if BP ≥140/90: Start labetalol/nifedipine/methyldopa (see table above)
- Severe features (BP ≥160/110): Admit; IV labetalol 20 mg bolus OR oral nifedipine 10 mg (repeat every 30 min PRN)
- Magnesium sulfate criteria: Severe pre-eclampsia with imminent/actual eclampsia OR during delivery if BP ≥160/110
- Regimen: 4 g IV loading over 5-15 min, then 1 g/h infusion for 24h
- Monitor: Respiratory rate ≥16/min, patellar reflexes, urine output ≥25 mL/h
- Delivery timing:
- Severe pre-eclampsia: Consider delivery from 34 weeks (balance maternal/fetal risk)
- Uncontrolled BP/organ dysfunction: Deliver urgently regardless of gestation
- Gestational hypertension alone: Aim for 37-40 weeks
⚠️ Warning: Rapid BP reduction (target 135/85, NOT normotension) risks placental hypoperfusion and fetal compromise
Analysis Framework
Differential Diagnosis: Hypertension in Pregnancy
| Feature | Chronic HTN | Gestational HTN | Pre-eclampsia | Severe Pre-eclampsia |
|---|---|---|---|---|
| Onset | <20 weeks | ≥20 weeks | ≥20 weeks | ≥20 weeks |
| Proteinuria | Absent | Absent | Present | Present |
| Organ dysfunction | Absent | Absent | May be present | Always present |
| BP threshold | ≥140/90 | ≥140/90 | ≥140/90 | ≥160/110 |
| Risk of eclampsia | Low | Low | Moderate | High |
🎯 Key Discriminators
- Proteinuria distinguishes gestational HTN from pre-eclampsia
- Severe BP/organ dysfunction mandates magnesium sulfate consideration
- HELLP syndrome (Haemolysis, Elevated Liver enzymes, Low Platelets): variant of severe pre-eclampsia requiring urgent delivery
Visual Aid
Key Points Summary
✓ Diagnostic thresholds: Gestational HTN ≥140/90 (no proteinuria); pre-eclampsia ≥140/90 + proteinuria/organ dysfunction; severe ≥160/110 or organ involvement
✓ First-line drugs: Labetalol 100 mg BD → 800 mg TDS, nifedipine MR 10 mg BD → 40 mg BD, methyldopa 250 mg BD-TDS → 1 g TDS
✓ Target BP 135/85 mmHg (avoid over-treatment)
✓ Magnesium sulfate: 4 g IV load + 1 g/h infusion for severe pre-eclampsia with imminent eclampsia or during delivery if BP ≥160/110
✓ Delivery timing: Severe pre-eclampsia from 34 weeks; urgent delivery if uncontrolled BP/organ dysfunction
✓ Monitor MgSO4: Respiratory rate ≥16/min, reflexes present, urine output ≥25 mL/h (toxicity antidote: calcium gluconate 10 mL 10% IV)
✓ HELLP syndrome is severe pre-eclampsia variant requiring urgent delivery
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app